Navigation Links
Hiemstra Approved to Manufacture Medical Devices in New CER
Date:1/9/2008

Meeting medical clients' needs from product design and development through

manufacturing

SAN FRANCISCO, Jan. 9 /PRNewswire/ -- Hiemstra Product Development, a leading product design and development company, announced today that it has received Food and Drug Branch (FDB) approval from the California Department of Health Services' Division of Food, Drug and Radiation Safety to manufacture class I - III medical devices in its 750 sq. ft., class 10,000 CER (clean room). Hiemstra can now help customers bring their medical technologies from concept to clinical release faster than before by offering world class product design and development, as well as manufacturing services, all under one roof.

This FDB approval enables Hiemstra to be a valuable manufacturing resource for customers through first-in-man, ongoing clinical trials, and low-to-mid volume production needs during early ramp-up or as ongoing manufacturing support. A few examples of the types of devices that Hiemstra's state-of-the-art CER can support are implants, surgical tools, catheters and catheter-based delivery systems.

"Now, Hiemstra is better equipped to increase speed-to-market by offering not only leading product design and development, but also manufacturing, in a one-stop-shop facility," noted Patrick Owens, Director of Operations at Hiemstra. "Our CER provides the flexibility to manufacture a few hundred to 30,000 units depending on the medical technology."

The engineering team at Hiemstra maintains in-depth knowledge of manufacturing processes to provide clients with additional support to ensure appropriate production resources are selected and to ensure a smooth transition to a high-volume production facility, as needed.

About Hiemstra:

Hiemstra Product Development is a leading medical product design and development company. Founded in 1991, this San Francisco-based firm is built on its unparalleled integration of indus
'/>"/>

SOURCE Hiemstra Product Development
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. RNs Statement on Death of Nataline Sarkisyan: CIGNA Should Have Listened to her Doctors and Approved the Transplant a Week Ago
2. Pennsylvania American Waters Rate Case Approved
3. PEGINTRON(TM) and REBETOL(R) Approved in European Union for Retreating Hepatitis C Patients Who Failed Previous Pegylated or Non-Pegylated Interferon Therapy
4. Barrs Generic Version of Estrostep(R) Fe Tablets Approved
5. A fresh look at existing therapies: Researchers explore ways to teach approved drugs new tricks
6. Voltaren(R) Gel Receives US Regulatory Approval as the First Approved Topical Prescription Treatment for Pain Associated with Osteoarthritis
7. Optometry-Backed Vision Care for Kids Act Approved by U.S. House
8. Video: New FDA-Approved Sun Protectant Saves Skin All Year Round
9. FDA Cracks Down on Unapproved Cough Medicines
10. $52.5 Million Settlement Against Sepracor Inc. Approved
11. Ranbaxy Receives Final Approval to Manufacture and Market Cetirizine Hydrochloride Tablets (OTC), 5mg and 10mg

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...lif., Dec. 1 The first nutrition b...s acclaimed for its potential to forestall the rav..., (Photo: http://www.newscom.com/cgi-bin/prnh/20....com/cgi-bin/prnh/20091111/NY08935LOGO ) ,, Th...z, Inc. of Rancho Santa Fe, Calif. contains as muc...
(Date:12/1/2009)...1 , - At ECPA,s Food Supp...ion and Modes of Agriculture Will Require Science-...Chief Scientific Adviser to the UK government,ass... on science and have a,sound evidence basis. "Havi...ity to look at all stages of policy development ha...
(Date:12/1/2009)... may up chances of disease, study finds , ... may actually boost the risk of breast cancer in s...tch researchers analyzed six previously published ...iation exposure from mammography among women with ...nd two looking at the effect of radiation from scr...
(Date:12/1/2009)... study accepted for publication in The Endocrine S...bolism ( JCEM ), youth with type 1 diabetes have .... Having abnormal insulin resistance appears to n...function in this population. , Type 1 diabetes ...abetes have their insulin resistance measured rout...
(Date:12/1/2009)...NDIANAPOLIS, Dec. 1 Expr... Inc. (NYSE: WLP ), announced today the closing ...tRx subsidiaries. ,, (Logo: http://www.newsco...ogo: http://www.newscom.com/cgi-bin/prnh/2008082...des a 10-year agreement under which Express Script...
Breaking Medicine News(10 mins):Health News:First Resveratrol Nutrition Bar Hits the Market 2Health News:Food Security to be the Top Issue for EU's Science Chief 2Health News:Mammograms May Boost Cancer Risk in High-Risk Women 2Health News:Cardiovascular risk in youth with type 1 diabetes linked primarily to insulin resistance 2Health News:Express Scripts Completes Acquisition of WellPoint's NextRx Subsidiaries 2Health News:Express Scripts Completes Acquisition of WellPoint's NextRx Subsidiaries 3Health News:Express Scripts Completes Acquisition of WellPoint's NextRx Subsidiaries 4Health News:Express Scripts Completes Acquisition of WellPoint's NextRx Subsidiaries 5Health News:Express Scripts Completes Acquisition of WellPoint's NextRx Subsidiaries 6
...cornmeal with folic acid markedly reduces the numb...pina bifida, say researchers according to a new st...ake folic acid supplements in early pregnancy when...of neural tube defects in babies born in Newfoundl...
...fects more than 80 percent of teenagers and up to ...cited // as a source of acne, these claims have be...sity students participated in this study. Each par...re recorded using the Perceived Stress Scale, whic...
...are at a higher risk of developing restless legs s... urge to move the legs and is generally accompanie...ations. Patients also report an increase in sympto... Researchers say they found that pregnant study ...
...more likely to develop ischemic heart disease as a...ed //, according to a new study. Stressful childho...as smoking, drug abuse, and inactivity. This may c... physical neglect, or household dysfunction (i.e. ...
...sk for life-threatening cardiovascular diseases, p...ll // advised to monitor their blood sugar levels ... new study. Researchers conducted a meta-analys...that blood sugar levels play a role in the develop...
...best friend might be able to detect bladder cancer...gs can smell odors from malignant tumors in urine ...ere trained over seven months to discriminate betw...s and one bladder cancer patient. The dogs identif...
Other Medicine News:
(Date:11/30/2009)... -- Breast-Specific Gamma Imaging (BSGI) has been ...for the detection of ductal carcinoma in situ (DCI... a molecular breast imaging technique that can see...r very early stage cancers. According to findings ...logical Society of North America (RSNA), BSGI is a...
(Date:11/30/2009)... The Eleventh Annual Southeastern ...the Charleston Place Hotel in the historic distric...heryl Liljestrand, Dr. Harry Guttman, and Dr. Jere..., will attend. SEBIO 2009 promises to bring innov...s, entrepreneurs, and service providers from aroun...
(Date:11/30/2009)...ewswire/ -- Reportlinker.com announces that a new ...ue: ,, Europe Ophthalmic Devices Investment Op... http://www.reportlinker.com/p0166515/Europe-Opht...nd-Forecasts-to-2015.html ,, Europe Ophthalmic...recasts to 2015 ,, Summary ,, This report ...
Breaking Medicine Technology:Breast-Specific Gamma Imaging Proves Highly Sensitive for the Detection of Ductal Carcinoma In Situ 2Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 2Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 3Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 4Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 5Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 6Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 7Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 8Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 9Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 10Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 11Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 12Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 13Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 14Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 15Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 16 28RED 29ZONES Launch at First U2 360 Degrees Concert in Barcelona 50678 1 28RED 29ZONES Launch at First U2 360 Degrees Concert in Barcelona 50678 2 28RED 29ZONES Launch at First U2 360 Degrees Concert in Barcelona 50678 3ACT Announces Partnership With Gilead Sciences Inc 12883 1Nu Skin Enterprises to Announce Second Quarter 2009 Results 50675 1
...RANCISCO, Oct. 25 BiPar Sciences, Inc., a,private... cancer therapies,today announced molecular biomar...ARP (poly-ADP-ribose polymerase) protein in multip...rs. The research is the first,demonstration of PAR...,insight is being used to guide the clinical devel...
...nificant anti-tumor activity of combination IV bel...r reported -, - Oral belinostat demonstrated to be...tion of results from two NCI-sponsored clinical tr...ference call today at 5:00 p.m. ...5 CuraGen Corporation,(Nasdaq: CRGN ), a clinica...
Other Medicine Technology:BiPar Genomic Biomarker Data Demonstrate Overexpression of PARP-1 Gene in Multiple Cancer Types 2CuraGen and TopoTarget Announce Presentation of Belinostat Clinical Trial Results at AACR-NCI-EORTC International Conference 2CuraGen and TopoTarget Announce Presentation of Belinostat Clinical Trial Results at AACR-NCI-EORTC International Conference 3CuraGen and TopoTarget Announce Presentation of Belinostat Clinical Trial Results at AACR-NCI-EORTC International Conference 4CuraGen and TopoTarget Announce Presentation of Belinostat Clinical Trial Results at AACR-NCI-EORTC International Conference 5CuraGen and TopoTarget Announce Presentation of Belinostat Clinical Trial Results at AACR-NCI-EORTC International Conference 6CuraGen and TopoTarget Announce Presentation of Belinostat Clinical Trial Results at AACR-NCI-EORTC International Conference 7CuraGen and TopoTarget Announce Presentation of Belinostat Clinical Trial Results at AACR-NCI-EORTC International Conference 8CuraGen and TopoTarget Announce Presentation of Belinostat Clinical Trial Results at AACR-NCI-EORTC International Conference 9
ProtoCLAIMS
...'s DrWorks offering is a medical practice manageme... and interfaces. This medical practice management ...raphics, insurance company information, encounter ...nic claims filing capabilities, electronic claims ...
A.I.med's medical billing software
HCS INTERACTANT Application Financial System Solutions
Medicine Products: